MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 51 filers reported holding MYMD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 4.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,189 | -60.5% | 120,252 | 0.0% | 0.00% | – |
| Q2 2023 | $180,378 | -12.8% | 120,252 | 0.0% | 0.00% | – |
| Q1 2023 | $206,833 | -11.6% | 120,252 | -40.9% | 0.00% | – |
| Q4 2022 | $234,030 | -12.0% | 203,504 | +100.0% | 0.00% | – |
| Q3 2022 | $266,000 | +20.4% | 101,752 | 0.0% | 0.00% | – |
| Q2 2022 | $221,000 | -53.4% | 101,752 | 0.0% | 0.00% | – |
| Q1 2022 | $474,000 | -4.0% | 101,752 | +24.7% | 0.00% | – |
| Q4 2021 | $494,000 | -15.8% | 81,586 | 0.0% | 0.00% | – |
| Q3 2021 | $587,000 | +257.9% | 81,586 | +213.0% | 0.00% | – |
| Q2 2021 | $164,000 | – | 26,063 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shay Capital LLC | 321,187 | $1,497,000 | 0.19% |
| Corundum Group, Inc. | 19,600 | $91,000 | 0.08% |
| Ikarian Capital, LLC | 131,389 | $612,000 | 0.08% |
| M Holdings Securities, Inc. | 70,909 | $330,000 | 0.02% |
| 683 Capital Management, LLC | 59,410 | $277,000 | 0.02% |
| Western Wealth Management, LLC | 30,713 | $143,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 1,095,418 | $5,104,000 | 0.01% |
| Qube Research & Technologies Ltd | 20,896 | $97,000 | 0.00% |
| MORGAN STANLEY | 908,576 | $4,234,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,690 | $64,000 | 0.00% |